358 related articles for article (PubMed ID: 8430886)
1. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
Diamant M; De Wied D
Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
[TBL] [Abstract][Full Text] [Related]
2. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats.
Diamant M; de Wied D
Endocrinology; 1991 Jul; 129(1):446-54. PubMed ID: 2055199
[TBL] [Abstract][Full Text] [Related]
3. Barrel rotation induced by central arginine8-vasopressin treatment: involvement of neurohypophyseal peptide receptors.
Diamant M; Baars AM; Kovács GL; De Wied D
Pharmacol Biochem Behav; 1994 Jan; 47(1):27-32. PubMed ID: 8115425
[TBL] [Abstract][Full Text] [Related]
4. Cardiac, neuroendocrine, and behavioral effects of central amygdaloid vasopressinergic and oxytocinergic mechanisms under stress-free conditions in rats.
Roozendaal B; Schoorlemmer GH; Koolhaas JM; Bohus B
Brain Res Bull; 1993; 32(6):573-9. PubMed ID: 8221155
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
Wan R; Diamant M; de Jong W; de Wied D
Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
[TBL] [Abstract][Full Text] [Related]
6. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
Poulin P; Komulainen A; Takahashi Y; Pittman QJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
[TBL] [Abstract][Full Text] [Related]
7. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
Diamant M; de Wied D
Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
[TBL] [Abstract][Full Text] [Related]
8. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
Johnson JV; Bennett GW; Hatton R
J Cardiovasc Pharmacol; 1988 Oct; 12(4):405-12. PubMed ID: 2465440
[TBL] [Abstract][Full Text] [Related]
9. The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats.
Diamant M; Croiset G; de Wied D
Peptides; 1992; 13(6):1149-58. PubMed ID: 1494497
[TBL] [Abstract][Full Text] [Related]
10. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E
Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
De Wied D; Gaffori O; Van Ree JM; De Jong W
Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular treatment with vasopressin V1-receptor antagonist inhibits centrally-mediated pressor response to clonidine in conscious rats.
Nakamura S; Kawasaki H; Takasaki K
Jpn J Pharmacol; 1993 Dec; 63(4):447-53. PubMed ID: 8121079
[TBL] [Abstract][Full Text] [Related]
13. Central ANP attenuates pressor responses to central AVP in WKY and SHR.
Stepniakowski K; Budzikowski A; Lon S; Szczepanska-Sadowska E
Brain Res Bull; 1991 Aug; 27(2):247-9. PubMed ID: 1835898
[TBL] [Abstract][Full Text] [Related]
14. Differential cardiovascular effects of centrally administered vasopressin in conscious Long Evans and Brattleboro rats.
Harland D; Gardiner SM; Bennett T
Circ Res; 1989 Oct; 65(4):925-33. PubMed ID: 2791228
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
Federico P; Veale WL; Pittman QJ
Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
[TBL] [Abstract][Full Text] [Related]
16. Central cardiovascular effects of AVP and AVP analogs with V1, V2 and 'V3' agonistic or antagonistic properties in conscious dog.
Noszczyk B; Lon S; Szczepańska-Sadowska E
Brain Res; 1993 Apr; 610(1):115-26. PubMed ID: 8518919
[TBL] [Abstract][Full Text] [Related]
17. Further evidence for a dissociation of peripheral and central effects of vasopressin.
Gaffori O; de Wied D
Psychoneuroendocrinology; 1985; 10(4):439-44. PubMed ID: 4089084
[TBL] [Abstract][Full Text] [Related]
18. Alterations in sensitivity to intracerebral vasopressin and the effects of a V1a receptor antagonist on cellular, autonomic and endocrine responses to repeated stress.
Chen X; Herbert J
Neuroscience; 1995 Feb; 64(3):687-97. PubMed ID: 7715781
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin analgesia: specificity of action and non-opioid effects.
Kordower JH; Bodnar RJ
Peptides; 1984; 5(4):747-56. PubMed ID: 6494025
[TBL] [Abstract][Full Text] [Related]
20. Role of L-glutamate in systemic AVP-induced hypothermia.
Paro FM; Almeida MC; Carnio EC; Branco LG
J Appl Physiol (1985); 2003 Jan; 94(1):271-7. PubMed ID: 12391090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
